M
Michael J. Mack
Researcher at Scott & White Hospital
Publications - 634
Citations - 36680
Michael J. Mack is an academic researcher from Scott & White Hospital. The author has contributed to research in topics: Valve replacement & Medicine. The author has an hindex of 89, co-authored 519 publications receiving 28877 citations. Previous affiliations of Michael J. Mack include Baylor University Medical Center & Medical City Dallas Hospital.
Papers
More filters
Journal ArticleDOI
Aortic Valve Replacement Surgery: Comparison of Outcomes in Matched Sternotomy and PORT ACCESS Groups
William T. Brinkman,William J. Hoffman,Todd M. Dewey,Dan Culica,Syma L. Prince,Morley A. Herbert,Michael J. Mack,William H. Ryan +7 more
TL;DR: The patients having aortic valve replacement using PORT ACCESS procedures, spent a shorter time in the intensive care unit and had less need for postoperative ventilator usage in comparison with patients undergoing conventional sternotomy.
Journal ArticleDOI
Comprehensive Analysis of Mortality Among Patients Undergoing TAVR: Results of the PARTNER Trial
Lars G. Svensson,Eugene H. Blackstone,Jeevanantham Rajeswaran,Nicholas A. Brozzi,Martin B. Leon,Craig R. Smith,Michael J. Mack,D. Craig Miller,Jeffrey W. Moses,E. Murat Tuzcu,John G. Webb,Samir R. Kapadia,Gregory P. Fontana,Raj Makkar,David L. Brown,Peter C. Block,Robert A. Guyton,Vinod H. Thourani,Augusto D. Pichard,Joseph E. Bavaria,Howard C. Herrmann,Mathew R. Williams,Vasilis Babaliaros,Philippe Généreux,Jodi J. Akin +24 more
TL;DR: In this article, the authors compared when and how deaths occurred after transcatheter aortic valve replacement (TAVR) versus surgical AVR or standard therapy (PARTNER-B arm) in the PARTNER (Placement of Aortic Transcatheter Valves) trial.
Journal ArticleDOI
Minimally invasive surgical ablation of atrial fibrillation: six-month results.
James R. Edgerton,James H. McClelland,David Duke,Marc W. Gerdisch,Bryan M. Steinberg,Scott H. Bronleewe,Syma L. Prince,Morley A. Herbert,Shannon Hoffman,Michael J. Mack +9 more
TL;DR: Minimally invasive atrial fibrillation surgery is an effective treatment of paroxysmal atrial Fibrillation at 6 months and a more extensive lesion set seems to be required for treatment of persistent atrialfibrillation.
Journal ArticleDOI
Aortic valve replacement: Determinants of operative mortality
Guo-Wei He,Tea E. Acuff,William H. Ryan,Mark B. Douthit,Richard T. Bowman,Yang-Hui He,Michael J. Mack +6 more
TL;DR: This study was designed to investigate determinants of operative mortality for AVR with emphasis on concomitant coronary artery bypass grafting (CABG) and old age, and examined risk factors for operative mortality.
Journal ArticleDOI
Initial prospective multicenter clinical trial of robotically-assisted coronary artery bypass grafting.
Ralph J. Damiano,Harold A. Tabaie,Michael J. Mack,James R. Edgerton,Chandra Mullangi,W. Peter Graper,Sunil M. Prasad +6 more
TL;DR: This initial prospective multicenter trial documents the feasibility of robotically-assisted coronary bypass grafting and indicates that further trials are warranted to establish the safety and efficacy of this new technology.